Page last updated: 2024-10-22

am 580 and Diabetic Cardiomyopathies

am 580 has been researched along with Diabetic Cardiomyopathies in 1 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guleria, RS1
Singh, AB1
Nizamutdinova, IT1
Souslova, T1
Mohammad, AA1
Kendall, JA1
Baker, KM1
Pan, J1

Other Studies

1 other study available for am 580 and Diabetic Cardiomyopathies

ArticleYear
Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
    Journal of molecular and cellular cardiology, 2013, Volume: 57

    Topics: Animals; Benzoates; Bexarotene; Blood Glucose; Collagen; Diabetes Mellitus, Type 2; Diabetic Cardiom

2013